Home - Products - Others - Other Targets - 13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione

13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione

CAS No. 94154-89-9

13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione( 5-Allyl-13-dimethylpyrimidine-246(1H3H5H)-trione )

Catalog No. M19383 CAS No. 94154-89-9

13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione is a reagent of research interest in the study alkene cyclization.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione
  • Note
    Research use only, not for human use.
  • Brief Description
    13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione is a reagent of research interest in the study alkene cyclization.
  • Description
    13-Dimethyl-5-(2-propen-1-yl)-246(1H3H5H)-pyrimidinetrione is a reagent of research interest in the study alkene cyclization.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-Allyl-13-dimethylpyrimidine-246(1H3H5H)-trione
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    94154-89-9
  • Formula Weight
    196.2
  • Molecular Formula
    C?H??N?O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Singh P. & Paul K.: J. Heterocycl. Chem. 43 607 (2006) 2.Kawahara N. et. al.: Chem. Pharm. Bull. 33 4740 (1985)
molnova catalog
related products
  • Acetyl-(D-Arg10,Cys1...

    Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 is a cyclic octapeptide with MC4R agonism. Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 significantly increases heart rate and blood pressure.

  • CRSP-1

    Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin receptors. Inhibits formation of multinuclear osteoclasts with similar efficacy to CT in vitro. Suppresses food intake and increases body temperature in free-feeding rats, and significantly decreases plasma calcium levels in vivo.

  • Lapisteride

    Lapisteride (CS-891) a steroidal 5α-reductase inhibitor is used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia and may be effective in preventing or treating AGA .